New pill aims to silence stubborn coughs
NCT ID NCT07483489
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests an experimental drug called HW091077 for people with a chronic cough that lasts a year or more and doesn't improve with standard treatment. About 180 adults in China will receive either the drug or a placebo daily for 4 weeks. Researchers will measure cough frequency using a monitor and track symptom changes to see if the drug is safe and effective.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- HW091077 oral tablet
- What this could lead to
- If successful, this could lead to a new treatment option for people with chronic cough that doesn't respond to current therapies.
- What could go wrong
- This is an early Phase 2 trial with only 180 participants, so results may not confirm effectiveness or safety. The drug may not work better than a placebo.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for REFRACTORY CHRONIC COUGH are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New pill aims to silence chronic cough that Won't quit
- New pill aims to silence stubborn chronic cough
- New hope for chronic coughers: experimental drug enters final testing phase
- Can cough training and a natural inhaler silence chronic cough?
- New database aims to unravel mysteries of chronic cough
- New cough pill shows promise in clinical trial